Bulk Rituximab Immunological Product from Germany
Rituximab is a chimeric monoclonal antibody targeting CD20 on B-cells, used in lymphoma and autoimmune disease therapy. Classified under HTS 3002.13.0090 as an unmixed immunological product obtained via biotechnological processes, supplied in bulk for formulation. It regulates immunological processes as defined in chapter notes.
Duty Rate — Germany → United States
0%
Rate breakdown
9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Import Tips
• Submit IND or BLA documentation from FDA to prove therapeutic intent and avoid diagnostic reagent classification
• Use validated shipping containers with temperature loggers; temperature excursions above 8°C often result in rejection
• Avoid common error of declaring as 'parts' under 3006; confirm it's not a finished medical appliance